Nothing is perfect. That can certainly be said for the comprehensive front-health-page article the New York Times ran this Saturday, April 5, on the high cost of new type 1 diabetes tools. Read more
from DiabetesNews http://ift.tt/1hnAKOX
from DiabetesNews http://ift.tt/1hnAKOX